Please login to the form below

Not currently logged in
Email:
Password:

Nova appoints Richard Limb as head of quality assurance

He joins the privately-owned company from Pfizer

1198462Leicester, UK-based Nova Laboratories has appointed Richard Limb as its new head of quality assurance in a role that will see him support the overall needs of the business and its technical operations.

Prior to Nova, Limb served Pfizer as its head of quality for its aseptic services division and brings over 20 years’ experience in the healthcare industry.

He said: “The challenge ahead is to support Nova’s growth and expansion plans whilst simultaneously meeting the ever-increasing regulatory demands and expectations in the current market place.

Limb has also worked as a project section leader at 3M Healthcare covering all areas of drug development and commercialisation and significant ‘quality on the floor’ support to manufacturing across a number of roles and organisations.”

“The head of quality assurance is a significant role within Nova and has influence across the business,” said Roger Stainforth, head of group finance.

“He is not in post purely to provide technical excellence and improve our QA systems; these efforts need to be aligned to the strategic direction of the Nova group and support the overall commercial effort whilst ensuring regulatory compliance and best practice across the business units,” he continued.

Limb succeeds Neil Housley who joins Quotient Clinical as its vice president, quality assurance.

17th July 2017

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

What do Healthcare Professionals think about the inclusion of remote selling techniques?
Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...
APAC map
Pharmaceutical innovation in the APAC region
A first-of-its-kind study paints a vivid picture of the APAC region’s future...

Infographics